{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:22:49Z","timestamp":1790356969669,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["252215"],"award-info":[{"award-number":["252215"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0002\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0002\/2013"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0002\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0002\/2013"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["Pest-C\/EQB\/LA0006\/2013"],"award-info":[{"award-number":["Pest-C\/EQB\/LA0006\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/87016\/2012"],"award-info":[{"award-number":["SFRH\/BD\/87016\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/78127\/2011"],"award-info":[{"award-number":["SFRH\/BD\/78127\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.biotechadv.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T14:36:09Z","timestamp":1424961369000},"page":"1342-1354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"special_numbering":"P3","title":["Polymer-based nanoparticles for oral insulin delivery: Revisited approaches"],"prefix":"10.1016","volume":"33","author":[{"given":"Pedro","family":"Fonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1tia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-7553","authenticated-orcid":false,"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2015.02.010_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1211\/146080800128735935","article-title":"Oral delivery of proteins: effect of chicken and duck ovomucoid on the stability of insulin in the presence of \u03b1-chymotrypsin and trypsin","volume":"6","author":"Agarwal","year":"2000","journal-title":"Pharm Pharmacol Commun"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0010","series-title":"Advances and Challenges in Oral Delivery of Macromolecules","article-title":"Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors","author":"Ara\u00fajo","year":"2014"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0015","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1016\/j.biomaterials.2014.07.026","article-title":"The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium","volume":"35","author":"Ara\u00fajo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2004.12.016","article-title":"Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies","volume":"293","author":"Avadi","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nano.2009.04.007","article-title":"Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method","volume":"6","author":"Avadi","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0025","first-page":"860109","article-title":"Ex vivo evaluation of insulin nanoparticles using chitosan and Arabic gum","volume":"2011","author":"Avadi","year":"2011","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0035","first-page":"251","article-title":"The internal secretion of the pancreas","volume":"7","author":"Banting","year":"1922","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijpharm.2007.12.037","article-title":"Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies","volume":"356","author":"Bayat","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nano.2008.01.003","article-title":"Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives","volume":"4","author":"Bayat","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(99)00247-3","article-title":"Nanosphere based oral insulin delivery","volume":"65","author":"Carino","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jconrel.2012.11.005","article-title":"Polymeric hydrogels for oral insulin delivery","volume":"165","author":"Chaturvedi","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-010-9561-2","article-title":"Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents","volume":"12","author":"Chaudhury","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2004.02.002","article-title":"A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery","volume":"96","author":"Chen","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0080","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.addr.2012.10.010","article-title":"Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules","volume":"65","author":"Chen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biotechadv.2014.07.006","article-title":"A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules","volume":"32","author":"Choonara","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0100","series-title":"The Cell: A Molecular Approach","article-title":"The cell surface","author":"Cooper","year":"2000"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin\u2013phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damg\u00e9","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.21874","article-title":"Poly(\u03b5-caprolactone)\/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes","volume":"99","author":"Damg\u00e9","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0883911507088276","article-title":"Preparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for insulin delivery","volume":"23","author":"Davaran","year":"2008","journal-title":"J Bioact Compat Polym"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.addr.2013.01.002","article-title":"Targeted nanoparticles with novel non-peptidic ligands for oral delivery","volume":"65","author":"des Rieux","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/bm700916h","article-title":"Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system","volume":"9","author":"Deutel","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.carbpol.2014.04.048","article-title":"Decanoic acid grafted oligochitosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract","volume":"111","author":"Du","year":"2014","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0150","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1208\/s12249-011-9647-5","article-title":"Chitosan\u2013sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin","volume":"12","author":"Elsayed","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0155","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10611860410001693706","article-title":"Issues in oral nanoparticle drug carrier uptake and targeting","volume":"12","author":"Florence","year":"2004","journal-title":"J Drug Target"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4161\/biom.23246","article-title":"Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying","volume":"2","author":"Fonte","year":"2012","journal-title":"Biomatter"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0165","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0939-6411(03)00145-0","article-title":"Development of acrylic-based copolymers for oral insulin delivery","volume":"57","author":"Foss","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.colsurfb.2007.04.009","article-title":"Chitosan nanoparticle as protein delivery carrier\u2014systematic examination of fabrication conditions for efficient loading and release","volume":"59","author":"Gan","year":"2007","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF02867128","article-title":"Oral insulin: fact or fiction? Possibilities of achieving oral delivery for insulin","volume":"8","author":"Gowthamarajan","year":"2003","journal-title":"Resonance"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0195","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1208\/s12249-012-9807-2","article-title":"Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery","volume":"13","author":"Han","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-3659(03)00126-3","article-title":"Chitosan-based gastrointestinal delivery systems","volume":"89","author":"Hejazi","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4155\/tde.12.40","article-title":"Polymer-based oral peptide nanomedicines","volume":"3","author":"Herrero","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0210","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers' entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0168-3659(94)90072-8","article-title":"Mechanisms of absorption enhancement and tight junction regulation","volume":"29","author":"Hochman","year":"1994","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4155\/tde.10.109","article-title":"Nanoparticles and toxicity in therapeutic delivery: the ongoing debate","volume":"2","author":"Hossain","year":"2011","journal-title":"Ther Deliv"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cbdd.12318","article-title":"Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral insulin delivery","volume":"84","author":"Hosseininasab","year":"2014","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0245","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/app.30775","article-title":"A novel insulin oral delivery system assisted by cationic \u03b2-cyclodextrin polymers","volume":"115","author":"Huang","year":"2010","journal-title":"J Appl Polym Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2015.02.010_bb0250","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.nano.2012.07.005","article-title":"Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective","volume":"8","author":"Hunter","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0255","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","article-title":"Polysaccharide colloidal particles as delivery systems for macromolecules","volume":"47","author":"Janes","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0265","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.0400969101","article-title":"Intestinal villous M cells: an antigen entry site in the mucosal epithelium","volume":"101","author":"Jang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0270","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1208\/s12249-010-9488-7","article-title":"Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights","volume":"11","author":"Jelvehgari","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0275","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2009.02.015","article-title":"Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide\/protein absorption using cell-penetrating peptides","volume":"136","author":"Kamei","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1211\/0022357055434","article-title":"Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model","volume":"57","author":"Lane","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0290","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1211\/0022357044175","article-title":"Oil-based formulations for oral delivery of insulin","volume":"56","author":"Li","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2006.08.040","article-title":"Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats","volume":"329","author":"Li","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0305","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0310","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1211\/0022357022052","article-title":"Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats","volume":"55","author":"Liu","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2013.03.033","article-title":"Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin","volume":"448","author":"Liu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0325","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.10149","article-title":"Formulation pH modulates the interaction of insulin with chitosan nanoparticles","volume":"91","author":"Ma","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0320","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan\u2013insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2004.10.003","article-title":"Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles","volume":"288","author":"Mesiha","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0340","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0345","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.progpolymsci.2012.04.004","article-title":"Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review","volume":"37","author":"Mukhopadhyay","year":"2012","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0350","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.msec.2012.09.001","article-title":"Oral insulin delivery by self-assembled chitosan nanoparticles: In vitro and in vivo studies in diabetic animal model","volume":"33","author":"Mukhopadhyay","year":"2013","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0355","series-title":"Chitosan-based systems for biopharmaceuticals: delivery, targeting and polymer therapeutics","first-page":"3","article-title":"Chemical and technological advances in chitins and chitosans useful for the formulation of biopharmaceuticals","author":"Muzzarelli","year":"2012"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","article-title":"In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin","volume":"189","author":"Nielsen","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0370","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10717540902937471","article-title":"Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: stability studies towards digestive enzymes of the intestine","volume":"16","author":"Perera","year":"2009","journal-title":"Drug Deliv"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0375","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0380","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.cgh.2014.06.018","article-title":"Polymeric nanoparticle technologies for oral drug delivery","volume":"12","author":"Pridgen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0390","doi-asserted-by":"crossref","first-page":"S90-S","DOI":"10.1016\/j.toxlet.2007.05.250","article-title":"Toxicological in vivo studies of an oral insulin nanosystem","volume":"172","author":"Reis","year":"2007","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0385","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/17435390802398309","article-title":"Toxicological assessment of orally delivered nanoparticulate insulin","volume":"2","author":"Reis","year":"2008","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0400","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2009.01.011","article-title":"Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption","volume":"135","author":"Rekha","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","article-title":"Oral delivery of therapeutic protein\/peptide for diabetes\u2014future perspectives","volume":"440","author":"Rekha","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2007.11.052","article-title":"Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods","volume":"355","author":"Sadeghi","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0415","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.06.019","article-title":"Cyclodextrin\u2013insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery","volume":"325","author":"Sajeesh","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0425","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1208\/s12249-010-9390-3","article-title":"Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties","volume":"11","author":"Sandri","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1166\/jbn.2009.022","article-title":"Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization","volume":"5","author":"Santander-Ortega","year":"2009","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0440","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.colsurfb.2006.09.012","article-title":"Development and characterization of new insulin containing polysaccharide nanoparticles","volume":"53","author":"Sarmento","year":"2006","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2006.09.005","article-title":"Probing insulin's secondary structure after entrapment into alginate\/chitosan nanoparticles","volume":"65","author":"Sarmento","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0445","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","article-title":"Oral bioavailability of insulin contained in polysaccharide nanoparticles","volume":"8","author":"Sarmento","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0450","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0455","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1166\/jnn.2007.609","article-title":"Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation","volume":"7","author":"Sarmento","year":"2007","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0460","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2011.12.038","article-title":"Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics","volume":"440","author":"Sharma","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0465","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0470","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.biomaterials.2004.06.020","article-title":"Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption","volume":"26","author":"Smith","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0475","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10717540903223442","article-title":"Influence of polymers ratio on insulin-loaded nanoparticles based on poly-\u03b5-caprolactone and Eudragit\u00ae RS for oral administration","volume":"16","author":"Socha","year":"2009","journal-title":"Drug Deliv"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0490","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0480","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0485","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0495","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog Polym Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2015.02.010_bb0500","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/dmrr.207","article-title":"Development of oral insulin: progress and current status","volume":"18","author":"Still","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0505","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0510","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/02652040903515490","article-title":"Insulin\u2013S.O. (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation","volume":"27","author":"Sun","year":"2010","journal-title":"J Microencapsul"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0515","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/ar200234q","article-title":"pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications","volume":"45","author":"Sung","year":"2012","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0530","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2009.04.014","article-title":"The complexation between novel comb shaped amphiphilic polyallylamine and insulin\u2014towards oral insulin delivery","volume":"376","author":"Thompson","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0525","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2009.09.018","article-title":"The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin\u2014towards oral insulin delivery","volume":"383","author":"Thompson","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0520","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte\u2013insulin nanocomplexes by Caco-2 cells\u2014towards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0535","first-page":"1","article-title":"pH responsive polymeric nanoparticles for oral insulin delivery","author":"Tyagi","year":"2012","journal-title":"Int J Pharm Pharmacol Tech"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0540","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpb.2004.03.023","article-title":"Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs","volume":"58","author":"van der Merwe","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0545","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.biomaterials.2008.05.026","article-title":"Synthesis, characterization and in vitro biological properties of O-methyl free N, N, N-trimethylated chitosan","volume":"29","author":"Verheul","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0550","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/jps.21550","article-title":"Modified chitosans for oral drug delivery","volume":"98","author":"Werle","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0555","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0560","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0570","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2010.08.009","article-title":"Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles","volume":"41","author":"Woitiski","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2011.04.003","article-title":"Facilitated nanoscale delivery of insulin across intestinal membrane models","volume":"412","author":"Woitiski","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0565","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3109\/03639045.2011.653789","article-title":"Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles","volume":"38","author":"Woitiski","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0580","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1556-276X-7-299","article-title":"Novel preparation of PLGA\/HP55 nanoparticles for oral insulin delivery","volume":"7","author":"Wu","year":"2012","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.12.055","article-title":"HP55-coated capsule containing PLGA\/RS nanoparticles for oral delivery of insulin","volume":"425","author":"Wu","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0595","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2007.04.004","article-title":"Vesicles from pluronic\/poly(lactic acid) block copolymers as new carriers for oral insulin delivery","volume":"120","author":"Xiong","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0590","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.colsurfb.2013.06.019","article-title":"Pluronic P85\/poly(lactic acid) vesicles as novel carrier for oral insulin delivery","volume":"111","author":"Xiong","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0600","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1463-1326.2011.01546.x","article-title":"Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles","volume":"14","author":"Yang","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0605","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0610","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0615","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2010.04.006","article-title":"Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate\/chitosan nanoparticles","volume":"393","author":"Zhang","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0620","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biotechadv.2015.02.010_bb0625","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2012.06.054","article-title":"Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation","volume":"436","author":"Zhang","year":"2012","journal-title":"Int J Pharm"}],"updated-by":[{"DOI":"10.1016\/j.biotechadv.2015.12.017","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000}}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073497501500035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073497501500035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:10:49Z","timestamp":1777572649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073497501500035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":122,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S073497501500035X"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.02.010","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer-based nanoparticles for oral insulin delivery: Revisited approaches","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}